Clinical Trials Browser

Phase NA × OTHER × Immune Checkpoint Inhibition × Clear all

NCT04507750 2020-09-21

Camrelizumab Combined With Apatinib in the Treatment of Epithelial Ovarian Cancer

Phase NA Unknown

Immune Checkpoint Inhibition